These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11383231)

  • 1. Therapeutic inadequacy in spite of bioequivalency on replacing Fluctine with Fluocim.
    Albrecht J; Adler RH
    Swiss Med Wkly; 2001 Feb; 131(5-6):84. PubMed ID: 11383231
    [No Abstract]   [Full Text] [Related]  

  • 2. Antidepressants and breast-feeding.
    Ito S; Koren G
    Am J Psychiatry; 1997 Aug; 154(8):1174. PubMed ID: 9247421
    [No Abstract]   [Full Text] [Related]  

  • 3. How does grapefruit juice affect psychotropic medications?
    Wiens A
    J Psychiatry Neurosci; 2000 Mar; 25(2):198. PubMed ID: 10740993
    [No Abstract]   [Full Text] [Related]  

  • 4. Interaction between fluoxetine and haloperidol: pharmacokinetic and clinical implications.
    Avenoso A; Spinà E; Campo G; Facciolă G; Ferlito M; Zuccaro P; Perucca E; Caputi AP
    Pharmacol Res; 1997 Apr; 35(4):335-9. PubMed ID: 9264051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excretion of fluoxetine and its metabolite, norfluoxetine, in human breast milk.
    Taddio A; Ito S; Koren G
    J Clin Pharmacol; 1996 Jan; 36(1):42-7. PubMed ID: 8932542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoxetine distribution in human milk.
    Duffull SB; Begg EJ; Ilett KF
    J Clin Pharmacol; 1996 Nov; 36(11):1078-9. PubMed ID: 8973997
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of antidepressant pharmacotherapy on behavioral treatment adherence and smoking cessation outcome in a combined treatment involving fluoxetine.
    Hitsman B; Spring B; Borrelli B; Niaura R; Papandonatos GD
    Exp Clin Psychopharmacol; 2001 Nov; 9(4):355-62. PubMed ID: 11764011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple-dose pharmacokinetics of fluoxetine in healthy Mexican subjects.
    Carrasco-Portugal MC; Granados-Soto V; Reyes-García G; Medina-Santillán R; Herrera JE; Flores-Murrieta FJ
    Proc West Pharmacol Soc; 2001; 44():69-70. PubMed ID: 11793998
    [No Abstract]   [Full Text] [Related]  

  • 9. Decrease of valproic acid concentration in the blood when coprescribed with fluoxetine.
    Droulers A; Bodak N; Oudjhani M; Lefevre des Noettes V; Bodak A
    J Clin Psychopharmacol; 1997 Apr; 17(2):139-40. PubMed ID: 10950492
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetic interaction between fluoxetine and metoclopramide in healthy volunteers.
    Vlase L; Leucuta A; Farcau D; Nanulescu M
    Biopharm Drug Dispos; 2006 Sep; 27(6):285-9. PubMed ID: 16770757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoxetine disposition in patients with chronic hepatitis C treated with interferon-α.
    Furlanut M; Soardo G; Donnini D; Sechi L; Franceschi L
    Clin Pharmacokinet; 2010 Nov; 49(11):767-72. PubMed ID: 20923249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fluoxetine: relations between plasma concentration and therapeutic effects in 32 patients with major depression and treated with 20 mg/day].
    Bourdeaux R; Pannetier P; Younos C; Desor D; Lehr PR; Capolaghi B
    Encephale; 1998; 24(1):57-61. PubMed ID: 9559305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unsuspected poor metabolizer phenotypes of fluoxetine in bioavailability/bioequivalence studies from an indian population perspective. Retrospective pharmacokinetic data evaluation.
    Kandasamy M; Tripathy K; Ravi S; Kamath N; Pai B; Srinivas NR; Kristjansson F; Thangam S
    Arzneimittelforschung; 2010; 60(1):12-21. PubMed ID: 20184222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender based response to fluoxetine hydrochloride medication in endogenous depression.
    Bano S; Akhter S; Afridi MI
    J Coll Physicians Surg Pak; 2004 Mar; 14(3):161-5. PubMed ID: 15228850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of chiral and racemic fluoxetine and norfluoxetine across childbearing.
    Sit D; Perel JM; Luther JF; Wisniewski SR; Helsel JC; Wisner KL
    J Clin Psychopharmacol; 2010 Aug; 30(4):381-6. PubMed ID: 20631556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining bupropion SR with venlafaxine, paroxetine, or fluoxetine: a preliminary report on pharmacokinetic, therapeutic, and sexual dysfunction effects.
    Kennedy SH; McCann SM; Masellis M; McIntyre RS; Raskin J; McKay G; Baker GB
    J Clin Psychiatry; 2002 Mar; 63(3):181-6. PubMed ID: 11926715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative bioavailability of a new formulation of fluoxetine drops.
    Floriddia ML; Castorina M; Drago F
    Eur Rev Med Pharmacol Sci; 2000; 4(1-2):9-13. PubMed ID: 11409190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimates of nursing infant daily dose of fluoxetine through breast milk.
    Suri R; Stowe ZN; Hendrick V; Hostetter A; Widawski M; Altshuler LL
    Biol Psychiatry; 2002 Sep; 52(5):446-51. PubMed ID: 12242061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-dependent antidepressant pharmacogenomics: polymorphisms of the serotonin transporter and G protein beta3 subunit as predictors of response to fluoxetine and nortriptyline.
    Joyce PR; Mulder RT; Luty SE; McKenzie JM; Miller AL; Rogers GR; Kennedy MA
    Int J Neuropsychopharmacol; 2003 Dec; 6(4):339-46. PubMed ID: 14604448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fluoxetine].
    Gleiter CH; Volz HP
    Dtsch Med Wochenschr; 1997 Apr; 122(15):481-2. PubMed ID: 9147940
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.